Suppr超能文献

幽门螺杆菌检测与根除治疗对比即时内镜检查用于消化不良患者的管理:一项随机试验的6.7年随访

Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial.

作者信息

Lassen A T, Hallas J, Schaffalitzky de Muckadell O B

机构信息

Department of Medical Gastroenterology, Odense University Hospital, 5000 Odense C, Denmark.

出版信息

Gut. 2004 Dec;53(12):1758-63. doi: 10.1136/gut.2004.043570.

Abstract

BACKGROUND

Dyspepsia is a chronic disease with significant impact on the use of health care resources. A management strategy based on Helicobacter pylori testing has been recommended but the long term effect is unknown.

AIM

To investigate the long term effect of a test and treat strategy compared with prompt endoscopy for management of dyspeptic patients in primary care.

PATIENTS

A total of 500 patients presenting in primary care with dyspepsia were randomised to management by H pylori testing plus eradication therapy (n = 250) or by endoscopy (n = 250). Results of 12 month follow up have previously been presented.

METHODS

Symptoms, quality of life, and patient satisfaction were recorded during a three month period, a median 6.7 years after randomisation (range 6.1-7.3 years). Number of endoscopies, antisecretory medication, H pylori treatments, and hospital visits were recorded from health care databases for the entire follow up period.

RESULTS

Median age was 45 years; 28% were H pylori infected. Use of resources was registered in all 500 patients (3084 person years) of whom 312 completed diaries. We found no difference in symptoms between the two groups. Median proportion of days without symptoms was 0.52 (interquartile range 0.10-0.88) in the test and eradicate group versus 0.64 (0.14-0.90) in the prompt endoscopy group (p = 0.27) (mean difference 0.05 (95% confidence interval (CI) -0.03 to 0.14)). Compared with the prompt endoscopy group, the test and eradicate group underwent fewer endoscopies (mean difference 0.62 endoscopies/person (95% CI 0.38-0.86)) and used less antisecretory medication (mean difference 102 defined daily doses/person (95% CI -1 to 205)).

CONCLUSION

On a long term basis, a H pylori test and eradicate strategy is as efficient as prompt endoscopy for management of dyspeptic patients in primary care and reduces the use of endoscopy and antisecretory medication.

摘要

背景

消化不良是一种对医疗资源使用有重大影响的慢性病。已推荐基于幽门螺杆菌检测的管理策略,但长期效果未知。

目的

调查在基层医疗中,检测和治疗策略与立即进行内镜检查相比,对消化不良患者管理的长期效果。

患者

共有500名在基层医疗中出现消化不良症状的患者被随机分为两组,一组接受幽门螺杆菌检测加根除治疗(n = 250),另一组接受内镜检查(n = 250)。之前已公布12个月随访结果。

方法

在随机分组后中位数6.7年(范围6.1 - 7.3年)的三个月期间,记录症状、生活质量和患者满意度。从医疗保健数据库记录整个随访期间的内镜检查次数、抗分泌药物使用情况、幽门螺杆菌治疗次数和住院就诊次数。

结果

中位年龄为45岁;28%感染幽门螺杆菌。在所有500名患者(3084人年)中记录了资源使用情况,其中312人完成了日记记录。我们发现两组症状无差异。检测和根除组无症状天数的中位数比例为0.52(四分位间距0.10 - 0.88),立即内镜检查组为0.64(0.14 - 0.90)(p = 0.27)(平均差异0.05(95%置信区间(CI)-0.03至0.14))。与立即内镜检查组相比,检测和根除组接受的内镜检查较少(平均差异0.62次内镜检查/人(95%CI 0.38 - 0.86)),使用的抗分泌药物较少(平均差异102限定日剂量/人(95%CI -1至205))。

结论

长期来看,幽门螺杆菌检测和根除策略在基层医疗中对消化不良患者的管理与立即进行内镜检查一样有效,并减少了内镜检查和抗分泌药物的使用。

相似文献

3
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2003(2):CD001961. doi: 10.1002/14651858.CD001961.
5
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2001(3):CD001961. doi: 10.1002/14651858.CD001961.
8
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD001961. doi: 10.1002/14651858.CD001961.pub2.
9
WITHDRAWN: Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD001961. doi: 10.1002/14651858.CD001961.pub3.
10
Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy.
Arch Intern Med. 2003 Jul 14;163(13):1606-12. doi: 10.1001/archinte.163.13.1606.

引用本文的文献

1
Clinical Practice Guidelines for Functional Dyspepsia in Korea.
J Neurogastroenterol Motil. 2020 Jan 30;26(1):29-50. doi: 10.5056/jnm19209.
4
Helicobacter pylori and functional dyspepsia: an unsolved issue?
World J Gastroenterol. 2014 Jul 21;20(27):8957-63. doi: 10.3748/wjg.v20.i27.8957.
5
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review.
Clin Transl Gastroenterol. 2013 Mar 28;4(3):e32. doi: 10.1038/ctg.2013.3.
6
Current management strategies and emerging treatments for functional dyspepsia.
Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):187-94. doi: 10.1038/nrgastro.2013.11. Epub 2013 Feb 5.
7
Rate and yield of repeat upper endoscopy in patients with dyspepsia.
World J Gastroenterol. 2010 May 28;16(20):2520-5. doi: 10.3748/wjg.v16.i20.2520.
8
Managing dyspepsia.
Curr Gastroenterol Rep. 2009 Aug;11(4):288-94. doi: 10.1007/s11894-009-0042-2.
9
Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial.
Saudi J Gastroenterol. 2008 Apr;14(2):96-100. doi: 10.4103/1319-3767.39629.

本文引用的文献

1
Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy.
Arch Intern Med. 2003 Jul 14;163(13):1606-12. doi: 10.1001/archinte.163.13.1606.
2
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2003(2):CD001961. doi: 10.1002/14651858.CD001961.
5
Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Aliment Pharmacol Ther. 2002 Aug;16(8):1491-501. doi: 10.1046/j.1365-2036.2002.01306.x.
6
Review article: dyspepsia: how to manage and how to treat?
Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:95-104. doi: 10.1046/j.1365-2036.16.s4.12.x.
7
Dyspepsia management in primary care: a decision analysis of competing strategies.
Gastroenterology. 2002 May;122(5):1270-85. doi: 10.1053/gast.2002.33019.
10
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验